Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-30

Clinical Trial Update: Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing how nizatidine and lisinopril modulate heme oxygenase-1 in healthy subjects, with gastroparesis as the referenced condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril (Lisinopril)
  • Nizatidine (nizatidine)

Snippet

Sponsor: Adil Bharucha | Conditions: Gastroparesis | Phase 1 | Status: COMPLETED